BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29142365)

  • 41. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer.
    McLoughlin LC; O'Kelly F; O'Brien C; Sheikh M; Feeney J; Torreggiani W; Thornhill JA
    Ir J Med Sci; 2016 Feb; 185(1):101-5. PubMed ID: 25394725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The headless bone scan: an uncommon manifestation of metastatic superscan in carcinoma of the prostate.
    Massie JD; Sebes JI
    Skeletal Radiol; 1988; 17(2):111-3. PubMed ID: 3363378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gradual normalization of superscan in prostate cancer: A case report and literature review.
    Ogu J; Jayasekera M; Villanueva-Meyer J; Bhargava P
    Radiol Case Rep; 2023 Dec; 18(12):4323-4326. PubMed ID: 37789917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
    Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
    Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: hepatic 'superscan'.
    Basu S; Nair N
    Clin Nucl Med; 2004 Oct; 29(10):626-8. PubMed ID: 15365434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian cancer unmasked by technetium-99m bone scintigraphy and single-photon emission computed tomography-computed tomography.
    Verschueren J; Huyghe I; Van den Wyngaert T
    World J Nucl Med; 2019; 18(1):58-60. PubMed ID: 30774548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of
    Zhang L; He Q; Li W; Zhang R
    BMC Med Imaging; 2017 Jul; 17(1):46. PubMed ID: 28738834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A comparison of planar scintigraphy and MRI in the screening of skeletal metastases].
    Silit E; Başekim CC; Mutlu H; Pekkafali Z; Kizilkaya E; Karsli AF
    Tani Girisim Radyol; 2003 Sep; 9(3):357-61. PubMed ID: 14661604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications.
    Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C
    Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma.
    Kane RD; Paulson DF
    J Urol; 1977 May; 117(5):618-21. PubMed ID: 859203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is femoral uptake of Tc99m-methylene diphosphonate on bone scintigraphy in bronchogenic carcinoma an alarming sign: A case report and brief review of literature?
    Jung RS; Mittal BR; Santhosh S; Sood A; Bhattacharya A; Kapoor R
    Lung India; 2014 Jul; 31(3):280-1. PubMed ID: 25125820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single plasma sample method to assess disease activity in patients with bone metastases from carcinoma of the prostate.
    Nisbet AP; Shaw PJ; Blackford N; Edwards S; Fogelman I; Lazarus C; Maisey MN; Mashiter GD
    Br J Urol; 1986 Oct; 58(5):545-8. PubMed ID: 3096418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mediastinal Ectopic Parathyroid Adenoma in a Patient Followed for Colon Cancer and Chronic Renal Failure: A Challenging Case.
    Şahin E; Elboğa U; Yetişyiğit T; Kalender E
    J Med Imaging Radiat Sci; 2014 Sep; 45(3):335-338. PubMed ID: 31051988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in
    Koç ZP; Özcan Kara P; Akdeniz A; Yaldız M
    Mol Imaging Radionucl Ther; 2020 Apr; 29(2):85-87. PubMed ID: 32368881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidental Detection of Perinephric Urinary Leak on Bone Scintigraphy in a Patient with Urinary Bladder Carcinoma.
    Vadi SK; Dasagrandhi V; Bhattacharya A; Singh SK; Mittal BR
    Indian J Nucl Med; 2018; 33(1):68-70. PubMed ID: 29430122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Radiologic diagnosis of bone metastases recurrence in patients with prostate cancer treated strontium-89].
    Barysheva EV; Selivanov SP; Riannel' IuE; Velichko SA; Usynin EA; Usov VIu
    Vestn Rentgenol Radiol; 1999; (5):32-6. PubMed ID: 12717923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.